ROBERTO IACOVELLI
ROBERTO IACOVELLI
Fondazione Policlinico Agostino Gemelli IRCCS, Roma
Email verificata su policlinicogemelli.it
Titolo
Citata da
Citata da
Anno
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
F Pietrantonio, F Petrelli, A Coinu, M Di Bartolomeo, K Borgonovo, ...
European journal of cancer 51 (5), 587-594, 2015
4472015
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
R de Wit, J de Bono, CN Sternberg, K Fizazi, B Tombal, C Wülfing, ...
New England Journal of Medicine 381 (26), 2506-2518, 2019
2502019
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
S Antoun, E Lanoy, R Iacovelli, L Albiges‐Sauvin, Y Loriot, ...
Cancer 119 (18), 3377-3384, 2013
1802013
Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis
R Iacovelli, F Nolè, E Verri, G Renne, C Paglino, M Santoni, MC Rocca, ...
Targeted oncology 11 (2), 143-148, 2016
1242016
Metabolic phenotype of bladder cancer
F Massari, C Ciccarese, M Santoni, R Iacovelli, R Mazzucchelli, F Piva, ...
Cancer treatment reviews 45, 46-57, 2016
1102016
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
S Bracarda, R Iacovelli, L Boni, M Rizzo, L Derosa, M Rossi, L Galli, ...
Annals of Oncology 26 (10), 2107-2113, 2015
992015
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials
R Iacovelli, D Alesini, A Palazzo, P Trenta, M Santoni, L De Marchis, ...
Cancer treatment reviews 40 (2), 271-275, 2014
892014
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
M Santoni, U De Giorgi, R Iacovelli, A Conti, L Burattini, L Rossi, ...
British journal of cancer 109 (7), 1755-1759, 2013
822013
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
P Gazzaniga, A Gradilone, A Petracca, C Nicolazzo, C Raimondi, ...
Journal of cellular and molecular medicine 14 (8), 2073-2077, 2010
802010
Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort
R Iacovelli, G Cartenì, CN Sternberg, M Milella, M Santoni, G Di Lorenzo, ...
European journal of cancer 49 (9), 2134-2142, 2013
782013
The cardiovascular toxicity of abiraterone and enzalutamide in prostate cancer
R Iacovelli, C Ciccarese, E Bria, M Romano, E Fantinel, D Bimbatti, ...
Clinical genitourinary cancer 16 (3), e645-e653, 2018
742018
Tumor growth rate provides useful information to evaluate sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: an integrated analysis of the TARGET …
C Ferte, S Koscielny, L Albiges, L Rocher, JC Soria, R Iacovelli, Y Loriot, ...
European urology 65 (4), 713-720, 2014
722014
Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
R Iacovelli, A Palazzo, S Mezi, F Morano, G Naso, E Cortesi
Acta Oncologica 51 (7), 873-879, 2012
722012
Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney
E Risi, R Iacovelli, A Altavilla, D Alesini, A Palazzo, C Mosillo, P Trenta, ...
Urology 82 (2), 382-386, 2013
712013
Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma
R Iacovelli, E Lanoy, L Albiges, B Escudier
BJU International-British Journal of Urology 110 (11), 1747, 2012
672012
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum
A Frega, P Scirpa, R Corosu, M Verrico, ML Scarciglia, MR Primieri, ...
Anticancer research 27 (4C), 2743-2746, 2007
672007
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy
C Ciccarese, F Massari, R Iacovelli, M Fiorentino, R Montironi, ...
Cancer Treatment Reviews 54, 68-73, 2017
652017
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies
R Iacovelli, F Pietrantonio, A Farcomeni, C Maggi, A Palazzo, F Ricchini, ...
PLoS One 9 (9), e108940, 2014
652014
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
F Pietrantonio, C Cremolini, F Petrelli, M Di Bartolomeo, F Loupakis, ...
Critical reviews in oncology/hematology 96 (1), 156-166, 2015
642015
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors
M Santoni, A Conti, S Partelli, C Porta, CN Sternberg, G Procopio, ...
Annals of surgical oncology 22 (6), 2094-2100, 2015
612015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20